92 related articles for article (PubMed ID: 15083598)
1. Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trials.
Boersma E; Westerhout CM
Curr Opin Investig Drugs; 2004 Mar; 5(3):313-9. PubMed ID: 15083598
[TBL] [Abstract][Full Text] [Related]
2. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes.
Koller CF
Heart Lung; 2001; 30(5):321-9; quiz 330-1. PubMed ID: 11604974
[TBL] [Abstract][Full Text] [Related]
3. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Adgey AA
Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
[TBL] [Abstract][Full Text] [Related]
4. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
[TBL] [Abstract][Full Text] [Related]
5. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors.
Dobesh PP; Latham KA
Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642
[TBL] [Abstract][Full Text] [Related]
6. [Platelet glycoprotein IIB-IIIA receptor inhibitors in patients with ischemic heart disease].
Patti G; Fossati C; Manzoli A; D'Ambrosio A; Abbate A; Montesanti R; Di Sciascio G
Clin Ter; 2000; 151(4):301-6. PubMed ID: 11107681
[TBL] [Abstract][Full Text] [Related]
7. Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes.
Chew DP; Roffi M; Topol EJ
Prog Cardiovasc Dis; 2001; 44(3):195-206. PubMed ID: 11727277
[TBL] [Abstract][Full Text] [Related]
8. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
Braunwald E; Maseri A; Armstrong PW; Califf RM; Gibler WB; Hamm CW; Simoons ML; Van de Werf F
Eur Heart J; 1998 Apr; 19 Suppl D():D22-30. PubMed ID: 9597519
[TBL] [Abstract][Full Text] [Related]
9. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Sabatine MS; Jang IK
Am J Med; 2000 Aug; 109(3):224-37. PubMed ID: 10974186
[TBL] [Abstract][Full Text] [Related]
10. Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Subbarao VD; Phillips J; Stouffer GA
Am J Med Sci; 1999 Aug; 318(2):107-14. PubMed ID: 10452570
[TBL] [Abstract][Full Text] [Related]
11. Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Westerhout CM; Boersma E
Expert Opin Drug Saf; 2003 Jan; 2(1):49-58. PubMed ID: 12904124
[TBL] [Abstract][Full Text] [Related]
12. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
[TBL] [Abstract][Full Text] [Related]
13. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years?
Silva MA; Gandhi PJ
J Clin Pharm Ther; 2004 Dec; 29(6):497-510. PubMed ID: 15584937
[TBL] [Abstract][Full Text] [Related]
14. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
Galli M; Maggioni AP; Vassanelli C; Tavazzi L
Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
[TBL] [Abstract][Full Text] [Related]
15. [Role of GP IIb/IIIa blockers in clinical cardiology].
Rossi ML; Merlini PA
Recenti Prog Med; 2003 Oct; 94(10):440-3. PubMed ID: 14619191
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.
Gambhir DS; Mukhopadhyay S
Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774
[No Abstract] [Full Text] [Related]
17. Management of acute ischaemic coronary syndromes beyond aspirin therapy: role of glycoprotein IIb/IIIa antagonists.
Gambhir DS
Indian Heart J; 1998; 50(2):151-4. PubMed ID: 9622980
[No Abstract] [Full Text] [Related]
18. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
Obradović S; Gligić B; Djordjević D; Jovicić A; Romanović R; Ratković N; Dincić D; Orozović V; Nikolić G
Vojnosanit Pregl; 2001; 58(1):65-72. PubMed ID: 11419288
[No Abstract] [Full Text] [Related]
19. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients.
Lavi S; Gruberg L; Kapeliovich M; Hammerman H; Boulos M; Grenadier E; Aronson D; Markiewicz W; Beyar R
J Invasive Cardiol; 2005 Jun; 17(6):296-9. PubMed ID: 16003002
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Young JJ
J Invasive Cardiol; 2005 Jun; 17(6):300-1. PubMed ID: 16003003
[No Abstract] [Full Text] [Related]
[Next] [New Search]